Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/181831 |
Resumo: | To assess the effect of nesiritide on the endothelial function of iliac arteries following endothelia trauma. Right iliac artery trauma was created with a balloon catheter. Ten rabbits were treated with a 4-week subcutaneous injection of nesiritide at a fixed daily dose of 0.1mg/kg. Ten rabbits received daily normal saline injection. Plasma endothelin 1 (ET-1), nitric oxide (NO), and Von Willebrand Factor (vWF) were measured before and after the therapies. Tissue proliferating cell nuclear antigen (PCNA) was measured after the treatment. After the treatment, in the therapeutic group, the area under internal elastic membrane and the residual lumen area were higher than in the normal saline group (P <0.05). The plasma levels of ET-1 (91.6±6.8 vs 114.9±6.3 ng/L, P =0.001), vWF (134.6±10.8% vs 188.8±10.4%, P =0.001) and the ratio of PCNA positive expression (11.7±4.2% vs 36.2±11.4%, P =0.005) in the therapeutic group was lower than in the normal saline group, while the plasma levels of NO was higher (89.7±9.3 vs 43.5±5.3 μmol/L, P =0.001). Nesiritide inhibited remodeling of rabbit iliac artery following endothelial trauma. The inhibition of vascular remodeling may be related to the alleviated endothelial dysfunction and reduced expression of tissue proliferating cell nuclear antigen. |
id |
USP-31_f349a32038ca82dbb39b7c0060cbfcb5 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/181831 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbitsPlasma endothelin (ET-1)Nitric oxide (NO)von Willebrand Factor (vWF)Tissue proliferating cell nuclear antigenIliac arteryTo assess the effect of nesiritide on the endothelial function of iliac arteries following endothelia trauma. Right iliac artery trauma was created with a balloon catheter. Ten rabbits were treated with a 4-week subcutaneous injection of nesiritide at a fixed daily dose of 0.1mg/kg. Ten rabbits received daily normal saline injection. Plasma endothelin 1 (ET-1), nitric oxide (NO), and Von Willebrand Factor (vWF) were measured before and after the therapies. Tissue proliferating cell nuclear antigen (PCNA) was measured after the treatment. After the treatment, in the therapeutic group, the area under internal elastic membrane and the residual lumen area were higher than in the normal saline group (P <0.05). The plasma levels of ET-1 (91.6±6.8 vs 114.9±6.3 ng/L, P =0.001), vWF (134.6±10.8% vs 188.8±10.4%, P =0.001) and the ratio of PCNA positive expression (11.7±4.2% vs 36.2±11.4%, P =0.005) in the therapeutic group was lower than in the normal saline group, while the plasma levels of NO was higher (89.7±9.3 vs 43.5±5.3 μmol/L, P =0.001). Nesiritide inhibited remodeling of rabbit iliac artery following endothelial trauma. The inhibition of vascular remodeling may be related to the alleviated endothelial dysfunction and reduced expression of tissue proliferating cell nuclear antigen.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2020-12-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/18183110.1590/s2175-97902019000418430Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18430Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18430Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e184302175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/181831/168733Copyright (c) 2020 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLiu, Shu-Qin Zhang, Li-Ping Yan, Huan-Ying Zhang, Xing-Hua Wang, Le-Xin 2021-06-12T19:46:54Zoai:revistas.usp.br:article/181831Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-06-12T19:46:54Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits |
title |
Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits |
spellingShingle |
Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits Liu, Shu-Qin Plasma endothelin (ET-1) Nitric oxide (NO) von Willebrand Factor (vWF) Tissue proliferating cell nuclear antigen Iliac artery |
title_short |
Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits |
title_full |
Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits |
title_fullStr |
Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits |
title_full_unstemmed |
Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits |
title_sort |
Nesiritide protects endothelial function after ballooninduced trauma in the iliac artery in rabbits |
author |
Liu, Shu-Qin |
author_facet |
Liu, Shu-Qin Zhang, Li-Ping Yan, Huan-Ying Zhang, Xing-Hua Wang, Le-Xin |
author_role |
author |
author2 |
Zhang, Li-Ping Yan, Huan-Ying Zhang, Xing-Hua Wang, Le-Xin |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Liu, Shu-Qin Zhang, Li-Ping Yan, Huan-Ying Zhang, Xing-Hua Wang, Le-Xin |
dc.subject.por.fl_str_mv |
Plasma endothelin (ET-1) Nitric oxide (NO) von Willebrand Factor (vWF) Tissue proliferating cell nuclear antigen Iliac artery |
topic |
Plasma endothelin (ET-1) Nitric oxide (NO) von Willebrand Factor (vWF) Tissue proliferating cell nuclear antigen Iliac artery |
description |
To assess the effect of nesiritide on the endothelial function of iliac arteries following endothelia trauma. Right iliac artery trauma was created with a balloon catheter. Ten rabbits were treated with a 4-week subcutaneous injection of nesiritide at a fixed daily dose of 0.1mg/kg. Ten rabbits received daily normal saline injection. Plasma endothelin 1 (ET-1), nitric oxide (NO), and Von Willebrand Factor (vWF) were measured before and after the therapies. Tissue proliferating cell nuclear antigen (PCNA) was measured after the treatment. After the treatment, in the therapeutic group, the area under internal elastic membrane and the residual lumen area were higher than in the normal saline group (P <0.05). The plasma levels of ET-1 (91.6±6.8 vs 114.9±6.3 ng/L, P =0.001), vWF (134.6±10.8% vs 188.8±10.4%, P =0.001) and the ratio of PCNA positive expression (11.7±4.2% vs 36.2±11.4%, P =0.005) in the therapeutic group was lower than in the normal saline group, while the plasma levels of NO was higher (89.7±9.3 vs 43.5±5.3 μmol/L, P =0.001). Nesiritide inhibited remodeling of rabbit iliac artery following endothelial trauma. The inhibition of vascular remodeling may be related to the alleviated endothelial dysfunction and reduced expression of tissue proliferating cell nuclear antigen. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-09 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/181831 10.1590/s2175-97902019000418430 |
url |
https://www.revistas.usp.br/bjps/article/view/181831 |
identifier_str_mv |
10.1590/s2175-97902019000418430 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/181831/168733 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18430 Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18430 Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18430 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222915146285056 |